Bunnik, The Netherlands September 1 2016 – Alloksys Life Sciences BV, a biopharma SME based in The Netherlands, has been granted an Innovation Cedit (’Innovatiekrediet’) of 3.4 million EUR by…
This is the largest investment by a Singapore pharmaceutical manufacturer for clinical trial development ICM Pharma will have exclusive manufacturing and marketing rights for RESCAP® used in cardiothoracic surgery for…
Alloksys and AMRIF appoints Koos van Haasteren as CEO to gear up for RESCAP® platform development Utrecht, 28 December 2015 – The Dutch based Alloksys Life Sciences BV and AMRIF…